Election Conspiracies Are Moving From Rhetoric to Government Action

Attacks on the legitimacy of U.S. elections are no longer confined to conspiracy theories circulating online—they are increasingly shaping government action at the local level.

In Riverside County, Calif., Sheriff Chad Bianco seized roughly 650,000 ballots from a 2025 special election based on fraud allegations that election officials say stem from misleading interpretations of preliminary voting data. Courts have since intervened, with the California Supreme Court ordering the investigation paused while litigation continues.

I spoke with Jill Garvey, co-director of States at the Core, about what these escalating “election integrity” efforts mean for democracy and public trust.

Garvey says many of the activists driving these claims understand election systems far better than they let on—and are intentionally using confusion around technical election data to sow distrust in the voting process.

Even when election officials fully explain the data and publicly refute the allegations, she said, demands for investigations continue, helping fuel a broader narrative that elections cannot be trusted.

Garvey sees these efforts as part of a larger strategy testing how far local officials can go in challenging election systems and democratic norms.

But she also points to growing community-level organizing and civic engagement in response. The groups advancing these claims, she noted, are relatively small compared to the hundreds of thousands of voters affected by their actions—a reminder that local communities still have significant power to push back against efforts to undermine confidence in elections.

Where to Watch ‘Ask E. Jean,’ a New Documentary on the Wit, Fury and Fearlessness of E. Jean Carroll

E. Jean Carroll—the colorful author and advice columnist who beat Donald Trump in court twice—is finally getting the documentary treatment in Ask E. Jean, a film that is as poignant as it is entertaining.

Director Ivy Meeropol first reached out to Carroll after reading the devastating yet vibrant New York Magazine piece in which Carroll accused Trump of raping her in a Bergdorf Goodman dressing room decades earlier.

Carroll’s initial response: “I’d rather eat my shoe.”

But Meeropol persisted, eventually convincing Carroll she wanted to tell the fuller story of her life—not just the trials, but her remarkable rise during the heyday of glossy magazines and New York media culture.

The resulting film traces Carroll’s evolution from Indiana cheerleader to professionally fabulous Manhattan raconteur, weaving together archival footage, legal depositions and deeply personal interviews.

Some of the documentary’s most powerful moments come from previously unseen deposition footage, where Carroll recounts the 1996 assault while enduring invasive questioning from Trump attorney Alina Habba. Even in those moments, Carroll remains irrepressibly funny.

Meeropol says the footage reveals “what really happens when someone who’s brought a charge of rape or sexual abuse is deposed,” while also exposing the broader misogyny women confront “from the minute we’re born.”

Meeropol also describes struggling against “The Trump Effect”—fear within the entertainment industry about supporting projects that could provoke retaliation from Trump or his allies. Distributors hesitated, some producers reportedly asked not to be credited, and the film was repeatedly stalled despite strong festival reviews.

But Ask E. Jean is now expanding into theaters nationwide, bringing Carroll’s story to audiences at a moment when the politics of gender, power and public accountability remain impossible to ignore.

Conservative Justices Resurrect the Comstock Act, Threatening Abortion Access Nationwide

On May 1, the Fifth U.S. Circuit Court of Appeals blocked the mailing of mifepristone, one of the most widely used abortion medications in the country, threatening access for patients already facing a shrinking number of clinics nationwide. Although the Supreme Court temporarily stayed the ruling earlier this month, Justice Clarence Thomas’ dissent revealed something even more alarming: a renewed effort to resurrect the Comstock Act, a 19th-century anti-obscenity law once used to criminalize the mailing of abortion- and contraception-related materials.

The Comstock Act’s history is deeply tied to censorship, moral policing and attacks on marginalized communities. Under its broad and subjective definition of “obscenity,” authorities targeted contraception, abortion information, sexual health materials, queer literature and even works of classical art. Its reproductive restrictions disproportionately harmed poor and working-class women, who were often cut off from the safest and most affordable forms of care.

Today, antiabortion activists are once again looking to Comstock as a tool to restrict abortion nationwide—this time through the courts. Thomas’ explicit invocation of the law in the mifepristone fight signals how far-right legal movements are attempting to revive long-discredited morality laws to roll back reproductive freedom and other established rights.

States Already Enacting Harmful SAVE Act Policies, Requiring Proof of Citizenship to Vote

Congressional Republicans are once again prioritizing the SAVE Act, legislation that would force Americans to show documents like a passport or birth certificate to register to vote. The House has already passed yet another version of the bill, but so far it has stalled in the Senate.

If the SAVE Act becomes law, it would block millions of eligible American citizens from voting.

As the Senate considers the SAVE Act, state legislatures are advancing similar “show-your-papers” policies. Florida, South Dakota and Utah have enacted similar laws in recent weeks. Other states that already have similar laws have experienced the difficulties of implementing them.

Including Arizona, which has had a proof-of-citizenship requirement for over 20 years, five states will have a show-your-papers requirement for all voters for the 2026 midterms: Arizona, New Hampshire, South Dakota, Utah and Wyoming. A sixth state, Louisiana, has one on the books that it has not yet implemented.

That’s a lot of strain on the election system to solve a problem that doesn’t exist. The U.S. Senate would be wise not to inflict those obstacles on every election official nationwide.

A Government for Big Tobacco and Bigger Families

The Department of Health and Human Services (HHS) made multiple headlines last week—starting with the apparent implosion of Dr. Marty Makary’s tenure as Food and Drug Administration commissioner. But beneath the chaos lies something more troubling: a federal health apparatus increasingly shaped by antiabortion pressure campaigns, pronatalist messaging and culture-war governance masquerading as public policy.

From the Supreme Court fight over mifepristone access to the Trump administration’s bizarre new moms.gov initiative—complete with links to antiabortion crisis pregnancy centers and rhetoric about Americans being “under-babied”—the week offered a revealing snapshot of where U.S. health policy is headed. Meanwhile, flavored vape approvals for Big Tobacco sailed through the FDA, even as reproductive healthcare access remains under constant attack.

Chaos may be Trump’s currency, but the throughline here is ideology: rewarding conservative allies, policing reproductive autonomy and repackaging motherhood as a nationalist project while offering little meaningful material support to actual families.

The Fifth Circuit Proves Abortion Is on the Ballot this November

A highlight of being in Ireland has been following the local news, especially the robust abortion beat: Irish lawmakers have been waging a loud fight to expand abortion rights—in particular, to ensure unnecessary waiting periods don’t impede access to care.

Breaking headlines from the United States were a dark juxtaposition.

The U.S. is one of only four nations worldwide actively rolling back reproductive rights.

And now we’re threatened with yet another fight: The Fifth Circuit Court of Appeals issued a ruling late last week aiming to create the most significant setback to abortion access since the Supreme Court’s Dobbs v. Jackson Women’s Health Organization decision four years ago.

The three-member panel, two of whom are Trump appointees, blocked a 2023 FDA policy allowing mifepristone to be prescribed by telehealth providers and delivered by mail—a decision that applies to all states, whether abortion is legal or not, and where voters have mobilized to pass ballot measures and enshrine reproductive rights in their state constitutions.

This Fifth Circuit ruling is not the final word on the case. The two pharmaceutical companies that make mifepristone, Danco and GenBioPro, immediately filed an emergency appeal to the Supreme Court. On Monday, Justice Samuel Alito announced an administrative stay through May 11, meaning the decision is on hold until at least then, while the justices review the appeal and decide whether the medically unnecessary in-person dispensing requirements can be reimposed for the duration of the litigation.

In the spirit of the fighting Irish, readers should take heart that the community of U.S. abortion providers, advocates and support networks “have shown amazing resilience and tenacity since the Dobbs decision,” according to Kelly Baden of Guttmacher. “They will continue to do what they can do to ensure that everyone, regardless of where they live, can access the abortion care they need.”

So, for now, our citizen mobilization strategy must be twofold: Support those who directly deliver those services and get ready to get loud. The abortion fight shows that access to healthcare, the integrity of science, the rules of democracy, and the right to bodily autonomy are not only all interconnected, but they are all on the ballot this November.

Tennessee Tries to Silence Women Nearly Killed by Its Abortion Ban: ‘We Will Have Our Day in Court,’ Pledges Lead Plaintiff

Tennessee was supposed to face nine women in court on April 27 in a closely watched trial over the state’s abortion ban—women who say they were denied emergency care, forced to flee the state for abortions, or pushed to the brink of death after suffering catastrophic pregnancy complications. After waiting nearly three years to testify publicly about what happened to them, the plaintiffs were prepared to finally take the stand.

Then, less than two business days before the trial was set to begin, Tennessee Attorney General Jonathan Skrmetti (yes, the same Skrmetti whose name is now attached to the Supreme Court’s landmark anti-trans healthcare ruling) filed an appeal invoking a newly enacted state law which prevents Tennesseans from suing over any state law that harms them. The move stripped the court of jurisdiction over the case, abruptly halting the proceedings and potentially delaying the trial for months or years.

“We should be in court today standing up to Tennessee’s abortion ban,” the Center for Reproductive Rights said in a statement after the cancellation. “These women deserve their day in court. But Tennessee politicians refuse to listen.”

Among the plaintiffs is Allie Phillips, who says she was forced to travel to New York for an abortion after learning her fetus had a fatal diagnosis and that continuing the pregnancy put her own life at risk. By the time she arrived for care, she learned the fetus had already died in utero, placing her at heightened risk of infection and blood clots.

Phillips shares her story and reaction to the canceled trial, in her own words.

“I would have testified about how I would have risked my future fertility and my life if I had stayed pregnant in Tennessee. … I already had a 6-year-old daughter, Adalie, to raise. She needed me to live and be her mom. …

“We’re appealing. We don’t know how it will take but even if it’s five years, we will have our day in court. I’m not going anywhere.”

The Courts Keep Targeting Abortion Pills. Patients and Providers Keep Finding Ways Around Them.

The U.S. Supreme Court has temporarily paused the Fifth Circuit’s Friday ruling that would have tightened access to mifepristone, preserving the current status quo while the justices consider the emergency appeal. The order keeps telehealth and mail access in place for now.

The Monday morning emergency action from the Court—which orders the Trump administration to answer by May 7—follows an urgent intervention from the manufacturers of mifepristone, GenBioPro and Danco.

Regardless of what the courts decide, international telehealth providers, community networks and websites selling pills are ready to ramp up services to fill the needs of Americans.

The Supreme Court Is Showing Us Why the ERA Can’t Wait

Listening to two recent Supreme Court arguments on immigration, I heard something more than a debate over statutory language or constitutional text. I heard a stark illustration of how precarious rights can be when they depend on interpretation rather than being firmly embedded in the Constitution.

In one case, justices parsed the meaning of a single word—“arrives”—in ways that risked erasing access to asylum altogether. In the other, they confronted a direct challenge to the 14th Amendment and, in doing so, were forced to reckon with the real lives at stake.

That contrast is the point. When a right lives in statute, it can be narrowed, redefined or even functionally denied through legal gymnastics that separate words from their purpose. But when a right is written into the Constitution, it becomes harder—though not impossible—for courts to ignore its human consequences.

The difference isn’t abstract; it shapes whether people can seek refuge, claim citizenship or be recognized as equal under the law.

Taken together, these cases offer a warning—and a roadmap. If we want rights to endure, they must be grounded where they are hardest to dismantle. The Equal Rights Amendment was meant to do exactly that. And in this moment, as courts and lawmakers test the limits of existing protections, the case for finally enshrining it in the Constitution has never been clearer.